Vaccine effectiveness evaluation
3 European H2020 organizations list this as part of their work — 3 as their primary capability.
Most active in this area
- EPICONCEPT
French epidemiology SME coordinating pan-European vaccine effectiveness studies and pandemic surveillance networks across 20 countries.
“Coordinated both I-MOVE-plus (platform to measure vaccine effects across Europe) and I-MOVE-COVID-19 (COVID-19 vaccine and treatment evaluation).”
PrimarySMEFR3 projects - MENINGITIS RESEARCH FOUNDATION
UK meningitis disease foundation contributing vaccine ethics, informed consent expertise, and influenza vaccine effectiveness research to EU health consortia.
“Participated in DRIVE (2017-2022), a RIA project on developing robust methodologies for measuring real-world influenza vaccine effectiveness.”
PrimarySMEUK2 projects - P95
Belgian epidemiology SME specialising in real-world vaccine effectiveness evaluation, disease burden modelling, and health economics for aging populations.
“Both DRIVE and VITAL centre on measuring vaccine effectiveness in real-world settings — DRIVE specifically on influenza vaccines, VITAL on vaccines in aging populations.”
PrimarySMEBE2 projects